1887

Chapter 94 : Hantaviruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Hantaviruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap94-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap94-2.gif

Abstract:

The hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) are rodent-borne zoonoses caused by certain members of the virus family , genus . Specific rodents (i.e., one or two closely related members of the order Rodentia) are the principal hosts of the hantaviruses known to cause human disease. The reverse transcription-PCR (RT-PCR) assays have been employed extensively to detect hantaviral RNA in clinical samples from HPS and HFRS patients and to obtain amplified products for viral characterization by DNA sequencing. Hantaviruses usually are extremely difficult to isolate from clinical materials. Thus, virus isolation is not commonly used for the diagnosis of hantaviral infections in humans. Neutralization of infectivity in vitro, immunofluorescent-antibody assays (IFAs), enzyme-linked immunosorbent assays (ELISAs), and a host of other serologic methods have been used to characterize hantaviruses isolated from clinical samples and rodents. The use of genetic sequence data to define taxonomic relationships within the genus has become increasingly important, in part because some hantaviruses have never been adapted to growth in cultured cells and because our knowledge of the serologic relationships among some of the hantaviral species is based on one strain per species. Early diagnosis is critical to the successful management of HFRS and HPS and, at least in the case of HPS caused by Andes virus, implementation of appropriate isolation procedures to prevent virus transmission to health care providers and other people.

Citation: Fulhorst C, Bowen M. 2011. Hantaviruses, p 1504-1513. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch94

Key Concept Ranking

Sin nombre virus
0.57785004
Hemorrhagic Fever With Renal Syndrome
0.44218794
0.57785004
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Electron micrograph of negatively stained Sin Nombre virus (2% phosphotungstic acid stain, pH 6.5). Courtesy of Charles Humphrey, Centers for Disease Control and Prevention. Humans usually become infected with hantaviruses by inhalation of aerosolized droplets of urine, saliva, or respiratory secretions from infected rodents or inhalation of aerosolized particles of feces, dust, or other organic matter contaminated with secretions or excretions from infected rodents. The aerosol transmission of hantaviruses from rodents to humans has been well documented (49, 110). Other means of infection include contamination of cutaneous injuries with infectious virus, contact of infectious materials with mucous membranes, ingestion of food contaminated with infectious rodent secretions or excretions, laboratory-acquired infections ( ), and—only in the case of Andes viruscontact with an HPS patient during the acute phase of illness ( ). Note that person-to-person hantavirus transmission has never been documented in Europe, Asia, or North America.

Citation: Fulhorst C, Bowen M. 2011. Hantaviruses, p 1504-1513. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch94
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Photomicrograph of human lung tissue showing hantaviral antigens in pulmonary microvasculature by using immunohistochemistry. Viral antigens are stained in red. Courtesy of Sherif Zaki, Centers for Disease Control and Prevention.

Citation: Fulhorst C, Bowen M. 2011. Hantaviruses, p 1504-1513. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch94
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816728.chap94
1. Aitichou, M.,, S. S. Saleh,, A. K. McElroy,, C. Schmaljohn,, and M. S. Ibrahim. 2005. Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR. J. Virol. Methods 124: 21 26.
2. Armstrong, L. R.,, S. R. Zaki,, M. J. Goldoft,, R. L. Todd,, A. S. Khan,, R. F. Khabbaz,, T. G. Ksiazek,, and C. J. Peters. 1995. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J. Infect. Dis. 172: 1166.
3. Bharadwaj, M.,, R. Nofchissey,, D. Goade,, F. Koster,, and B. Hjelle. 2000. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J. Infect. Dis. 182: 43 48.
4. Biel, S. S.,, O. Donoso Mantke,, K. Lemmer,, A. Vaheri,, A. Lundkvist,, P. Emmerich,, M. Hukic,, and M. Niedrig. 2003. Quality control measures for the serological diagnosis of hantavirus infections. J. Clin. Virol. 28: 248 256.
5. Bostik, P.,, J. Winter,, T. G. Ksiazek,, P. E. Rollin,, F. Villinger,, S. R. Zaki,, C. J. Peters,, and A. A. Ansari. 2000. Sin Nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. Emerg. Infect. Dis. 6: 184 187.
6. Castillo, C.,, J. Naranjo,, A. Sepulveda,, G. Ossa,, and H. Levy. 2001. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 120: 548 554.
7.Centers for Disease Control and Prevention. 1994. Laboratory management of agents associated with hantavirus pulmonary syndrome: interim biosafety guidelines. MMWR Recommend. Rep. 43: 17.
8. Chapman, L. E.,, G. J. Mertz,, C. J. Peters,, H. M. Jolson,, A. S. Khan,, T. G. Ksiazek,, F. T. Koster,, K. F. Baum,, P. E. Rollin,, A. T. Pavia,, R. C. Holman,, J. C. Christenson,, P. J. Rubin,, R. E. Behrman,, L. J. Bell,, G. L. Simpson,, R. F. Sadek, and the Ribavirin Study Group. 1999. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Antivir. Ther. 4: 211 219.
9. Cho, H. W.,, C. R. Howard,, and H. W. Lee. 2002. Review of an inactivated vaccine against hantaviruses . Intervirology 45: 328 333.
10. Choi, Y.,, C. J. Ahn,, K. M. Seong,, M. Y. Jung,, and B. Y. Ahn. 2003. Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. Vaccine 21: 1867 1873.
11. Chu, Y. K.,, G. Jennings,, A. Schmaljohn,, F. Elgh,, B. Hjelle,, H. W. Lee,, S. Jenison,, T. Ksiazek,, C. J. Peters,, P. Rollin,, and C. S. Schmaljohn. 1995. Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients. J. Infect. Dis. 172: 1581 1584.
12. Chu, Y. K.,, C. Rossi,, J. W. Leduc,, H. W. Lee,, C. S. Schmaljohn,, and J. M. Dalrymple. 1994. Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology 198: 196 204.
13. Clement, J.,, P. McKenna,, J. Groen,, A. Osterhaus,, P. Colson,, T. Vervoort,, G. Preventionen,, and H. W. Lee. 1995. Epidemiology and laboratory diagnosis of hantavirus (HTV) infections. Acta Clin. Belg. 50: 9 19.
14. Clement, J.,, and P. McKenna,. 1998. Hantaviruses, p. 331 351. In S. R. Palmer,, E. J. L. Soulsby,, and D. I. H. Simpson (ed.), Zoonoses, Biology, Clinical Practice and Public Health Control. Oxford University Press, New York, NY.
15. Crowcroft, N. S.,, A. Infuso,, D. Ilef,, B. Le Guenno,, J. C. Desenclos,, F. Van Loock,, and J. Clement. 1999. Risk factors for human hantavirus infection: Franco-Belgian collaborative case-control study during 1995-6 epidemic. Br. Med. J. 318: 1737 1738.
16. Custer, D. M.,, E. Thompson,, C. S. Schmaljohn,, T. G. Ksiazek,, and J. W. Hooper. 2003. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J. Virol. 77: 9894 9905.
16a.. Department of Health and Human Services. 2009. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. U.S. Government Printing Office, Washington, DC. http://www. cdc.gov/biosafety/publications/bmbl5/BMBL.pdf.
17. Duchin, J. S.,, F. T. Koster,, C. J. Peters,, G. L. Simpson,, B. Tempest,, S. R. Zaki,, T. G. Ksiazek,, P. E. Rollin,, S. Nichol,, E. T. Umland,, R. L. Moolenaar,, S. E. Reef,, K. B. Nolte,, M. M. Gallaher,, J. C. Butler,, R. F. Breiman, and The Hantavirus Study Group. 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330: 949 955.
18. Dzagurova, T. K.,, B. Klempa,, E. A. Tkachenko,, G. P. Slyusareva,, V. G. Morozov,, B. Auste,, and D. H. Kruger. 2009. Molecular diagnostics of hemorrhagic fever with renal syndrome during a Dobrava virus infection outbreak in the European part of Russia. J. Clin. Microbiol. 47: 4029 4036.
19. Elgh, F.,, M. Linderholm,, G. Wadell,, A. Tarnvik,, and P. Juto. 1998. Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol. Med. Microbiol. 22: 309 315.
20. Elgh, F.,, G. Wadell,, and P. Juto. 1995. Comparison of the kinetics of Puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescence test. J. Med.Virol. 45: 146 150.
21. Evander, M.,, I. Eriksson,, L. Pettersson,, P. Juto,, C. Ahlm,, G. E. Olsson,, G. Bucht,, and A. Allard. 2007. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J. Clin. Microbiol. 45: 2491 2497.
22. Fabbri, M.,, and M. J. Maslow. 2001. Hantavirus pulmonary syndrome in the United States. Curr. Infect. Dis. Rep. 3: 258 265.
22a.. Federal Register. 2002. Hazardous materials: revision to standards for infectious substances, final rule. Fed. Regist. 67: 5311853144.
22b.. Federal Register. 2006. Hazardous materials: infectious substances; harmonization with the United Nations Recommendations, final rule. Fed. Regist. 71: 3224432263.
23. Feldmann, H.,, A. Sanchez,, S. Morzunov,, C. F. Spiropoulou,, P. E. Rollin,, T. G. Ksiazek,, C. J. Peters,, and S. T. Nichol. 1993. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res. 30: 351 367.
24. Galeno, H.,, J. Mora,, E. Villagra,, J. Fernandez,, J. Hernandez,, G. J. Mertz,, and E. Ramirez. 2002. First human isolate of Hantavirus (Andes virus) in the Americas. Emerg. Infect. Dis. 8: 657 661.
25. Garin, D.,, C. Peyrefitte,, J. M. Crance,, A. Le Faou,, A. Jouan,, and M. Bouloy. 2001. Highly sensitive Taqman PCR detection of Puumala hantavirus. Microbes Infect. 3: 739 745.
26. Gavrilovskaya, I. N.,, M. Shepley,, R. Shaw,, M. H. Ginsberg,, and E. R. Mackow. 1998. ?3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA 95: 7074 7079.
27. Godoy, P.,, D. Marsac,, E. Stefas,, P. Ferrer,, N. D. Tischler,, K. Pino,, P. Ramdohr,, P. Vial,, P. D. Valenzuela,, M. Ferres,, F. Veas,, and M. Lopez-Lastra. 2009. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J. Virol. 83: 5046 5055.
28. Gott, P.,, R. Stohwasser,, P. Schnitzler,, G. Darai,, and E. K. Bautz. 1993. RNA binding of recombinant nucleocapsid proteins of hantaviruses. Virology 194: 332 337.
29. Groen, J.,, J. Dalrymple,, S. Fisher-Hoch,, J. G. Jordans,, J. P. Clement,, and A. D. Osterhaus. 1992. Serum antibodies to structural proteins of Hantavirus arise at different times after infection. J. Med. Virol. 37: 283 287.
30. Heider, H.,, B. Ziaja,, C. Priemer,, A. Lundkvist,, J. Neyts,, D. H. Kruger,, and R. Ulrich. 2001. A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies. J. Virol. Methods 96: 17 23.
31. Henderson, W. W.,, M. C. Monroe,, S. C. St. Jeor,, W. P. Thayer,, J. E. Rowe,, C. J. Peters,, and S. T. Nichol. 1995. Naturally occurring Sin Nombre virus genetic reassortants. Virology 214: 602 610.
32. Hjelle, B. 2002. Vaccines against hantaviruses. Expert Rev. Vaccines 1: 373 384.
33. Hjelle, B.,, F. Chavez-Giles,, N. Torrez-Martinez,, T. Yamada,, J. Sarisky,, M. Ascher,, and S. Jenison. 1994. Dominant glycoprotein epitope of Four Corners hantavirus is conserved across a wide geographical area. J. Gen. Virol. 75: 2881 2888.
34. Hjelle, B.,, S. Jenison,, N. Torrez-Martinez,, T. Yamada,, K. Nolte,, R. Zumwalt,, K. MacInnes,, and G. Myers. 1994. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J. Virol. 68: 592 596.
35. Horling, J.,, A. Lundkvist,, J. W. Huggins,, and B. Niklasson. 1992. Antibodies to Puumala virus in humans determined by neutralization test. J. Virol. Methods 39: 139 147.
36. Horling, J.,, A. Lundkvist,, K. Persson,, M. Mullaart,, T. Dzagurova,, A. Dekonenko,, E. Tkachenko,, and B. Niklasson. 1995. Detection and subsequent sequencing of Puumala virus from human specimens by PCR. J. Clin. Microbiol. 33: 277 282.
37. Huggins, J. W.,, C. M. Hsiang,, T. M. Cosgriff,, M. Y. Guang,, J. I. Smith,, Z. O. Wu,, J. W. LeDuc,, Z. M. Zheng,, J. M. Meegan,, Q. N. Wang,, D. D. Oland,, X. E. Gui,, P. H. Gibbs,, G. H. Yuan,, and T. M. Zhang. 1991. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 164: 1119 1127.
38. Huggins, J. W.,, G. R. Kim,, O. M. Brand,, and K. T. McKee, Jr. 1986. Ribavirin therapy for Hantaan virus infection in suckling mice. J. Infect. Dis. 153: 489 497.
39. Hujakka, H.,, V. Koistinen,, I. Kuronen,, P. Eerikainen,, M. Parviainen,, A. Lundkvist,, A. Vaheri,, O. Vapalahti,, and A. Narvanen. 2003. Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J. Virol. Methods 108: 117 122.
40. Hung, T.,, J. Y. Zhou,, Y. M. Tang,, T. X. Zhao,, L. J. Baek,, and H. W. Lee. 1992. Identification of Hantaan virus-related structures in kidneys of cadavers with haemorrhagic fever with renal syndrome. Arch. Virol. 122: 187 199.
41. Ivanov, A.,, O. Vapalahti,, H. Lankinen,, E. Tkachenko,, A. Vaheri,, B. Niklasson,, and A. Lundkvist. 1996. Biotinlabeled antigen: a novel approach for detection of Puumala virus-specific IgM. J. Virol. Methods 62: 87 92.
42. Iversson, L. B.,, A. P. da Rosa,, M. D. Rosa,, A. V. Lomar,, G. Sasaki Mda,, and J. W. LeDuc. 1994. Human infection by Hantavirus in southern and southeastern Brazil. Rev. Assoc. Med. Bras. 40: 85 92. (In Portuguese.)
43. Jaaskelainen, K. M.,, P. Kaukinen,, E. S. Minskaya,, A. Plyusnina,, O. Vapalahti,, R. M. Elliott,, F. Weber,, A. Vaheri,, and A. Plyusnin. 2007. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J. Med. Virol. 79: 1527 1536.
44. Jenison, S.,, T. Yamada,, C. Morris,, B. Anderson,, N. Torrez- Martinez,, N. Keller,, and B. Hjelle. 1994. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J. Virol. 68: 3000 3006.
45. Johnson, A. M.,, M. D. Bowen,, T. G. Ksiazek,, R. J. Williams,, R. T. Bryan,, J. N. Mills,, C. J. Peters,, and S. T. Nichol. 1997. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 238: 115 127.
46. Kallio-Kokko, H.,, R. Leveelahti,, M. Brummer-Korvenkontio,, A. Lundkvist,, A. Vaheri,, and O. Vapalahti. 2001. Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells. J. Med. Virol. 65: 605 613.
47. Kallio-Kokko, H.,, A. Lundkvist,, A. Plyusnin,, T. Avsic- Zupanc,, A. Vaheri,, and O. Vapalahti. 2000. Antigenic properties and diagnostic potential of recombinant Dobrava virus nucleocapsid protein. J. Med. Virol. 61: 266 274.
48. Kang, H. J.,, S. N. Bennett,, L. Sumibcay,, S. Arai,, A. G. Hope,, G. Mocz,, J. W. Song,, J. A. Cook,, and R. Yanagihara. 2009. Evolutionary insights from a genetically divergent hantavirus harbored by the European common mole (Talpa europaea). PLoS One 4: e6149.
49. Kawamata, J.,, T. Yamanouchi,, K. Dohmae,, H. Miyamoto,, M. Takahaski,, K. Yamanishi,, T. Kurata,, and H. W. Lee. 1987. Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab. Anim. Sci. 37: 431 436.
50. Khan, A. S.,, M. Gaviria,, P. E. Rollin,, W. G. Hlady,, T. G. Ksiazek,, L. R. Armstrong,, R. Greenman,, E. Ravkov,, M. Kolber,, H. Anapol,, E. D. Sfakianaki,, S. T. Nichol,, C. J. Peters,, and R. F. Khabbaz. 1996. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am. J. Med. 100: 46 48.
51. Khan, A. S.,, C. F. Spiropoulou,, S. Morzunov,, S. R. Zaki,, M. A. Kohn,, S. R. Nawas,, L. McFarland,, and S. T. Nichol. 1995. Fatal illness associated with a new hantavirus in Louisiana. J. Med. Virol. 46: 281 286.
52. Kitsutani, P. T.,, R. W. Denton,, C. L. Fritz,, R. A. Murray,, R. L. Todd,, W. J. Pape,, J. Wyatt Frampton,, J. C. Young,, A. S. Khan,, C. J. Peters,, and T. G. Ksiazek. 1999. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg. Infect. Dis. 5: 701 705.
53. Koster, F.,, K. Foucar,, B. Hjelle,, A. Scott,, Y. Y. Chong,, R. Larson,, and M. McCabe. 2001. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am. J. Clin. Pathol. 116: 665 672.
54. Koster, F. T.,, and H. Levy. 2007. Hantavirus Cardiopulmonary Syndrome: a New Twist to an Established Pathogen. Springer, New York, NY.
55. Kraus, A. A.,, C. Priemer,, H. Heider,, D. H. Kruger,, and R. Ulrich. 2005. Inactivation of Hantaan virus-containing samples for subsequent investigations outside biosafety level 3 facilities. Intervirology 48: 255 261.
56. Ksiazek, T. G.,, C. J. Peters,, P. E. Rollin,, S. Zaki,, S. Nichol,, C. Spiropoulou,, S. Morzunov,, H. Feldmann,, A. Sanchez,, A. S. Khan,, B. W. J. Mahy,, K. Wachsmuth,, and J. C. Butler. 1995. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am. J. Trop. Med. Hyg. 52: 117 123.
57. LeDuc, J. W.,, T. G. Ksiazek,, C. A. Rossi,, and J. M. Dalrymple. 1990. A retrospective analysis of sera collected by the Hemorrhagic Fever Commission during the Korean Conflict. J. Infect. Dis. 162: 1182 1184.
58. Lee, H. W.,, and K. M. Johnson. 1982. Laboratory-acquired infections with Hantaan virus, the etiologic agent of Korean hemorrhagic fever. J. Infect. Dis. 146: 645 651.
59. Lee, H. W.,, and G. van der Groen. 1989. Hemorrhagic fever with renal syndrome. Prog. Med. Virol. 36: 62 102.
60. Lee, P. W.,, C. J. Gibbs, Jr.,, D. C. Gajdusek,, and R. Yanagihara. 1985. Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests. J. Clin. Microbiol. 22: 940 944.
61. Li, D.,, A. L. Schmaljohn,, K. Anderson,, and C. S. Schmaljohn. 1995. Complete nucleotide sequences of the M and S segments of two hantavirus isolates from California: evidence for reassortment in nature among viruses related to hantavirus pulmonary syndrome. Virology 206: 973 983.
62. Linderholm, M.,, and F. Elgh. 2001. Clinical characteristics of hantavirus infections on the Eurasian continent. Curr. Top. Microbiol. Immunol. 256: 135 151.
63. Lloyd, G.,, and N. Jones. 1986. Infection of laboratory workers with hantavirus acquired from immunocytomas propagated in laboratory rats. J. Infect. 12: 117 125.
64. Lopez, N.,, P. Padula,, C. Rossi,, M. E. Lazaro,, and M. T. Franze-Fernandez. 1996. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220: 223 226.
65. Lu, Q.,, Z. Zhu,, and J. Weng. 1996. Immune responses to inactivated vaccine in people naturally infected with hantaviruses. J. Med. Virol. 49: 333 335.
66. Lukes, R. 1954. The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am. J. Med. 16: 639 650.
67. Lundkvist, A.,, S. Bjorsten,, and B. Niklasson. 1993. Immunoglobulin G subclass responses against the structural components of Puumala virus. J. Clin. Microbiol. 31: 368 372.
68. Lundkvist, A.,, M. Hukic,, J. Horling,, M. Gilljam,, S. Nichol,, and B. Niklasson. 1997. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J. Med. Virol. 53: 51 59.
69. Lundkvist, A.,, D. Wiger,, J. Horling,, K. B. Sjolander,, A. Plyusnina,, R. Mehl,, A. Vaheri,, and A. Plyusnin. 1998. Isolation and characterization of Puumala hantavirus from Norway: evidence for a distinct phylogenetic sublineage. J. Gen. Virol. 79( Pt. 11): 2603 2614.
70. Maes, P.,, J. Clement,, and M. Van Ranst. 2009. Recent approaches in hantavirus vaccine development. Expert Rev. Vaccines 8: 67 76.
71. Maes, P.,, E. Keyaerts,, J. Clement,, V. Bonnet,, A. Robert,, and M. Van Ranst. 2004. Detection of Puumala hantavirus antibody with ELISA using a recombinant truncated nucleocapsid protein expressed in Escherichia coli. Viral Immunol. 17: 315 321.
72. Maes, P.,, B. Klempa,, J. Clement,, J. Matthijnssens,, D. C. Gajdusek,, D. H. Kruger,, and M. Van Ranst. 2009. A proposal for new criteria for the classification of hantaviruses, based on S and M segment protein sequences. Infect. Genet. Evol. 9: 813 820.
73. Maes, P.,, S. Li,, J. Verbeeck,, E. Keyaerts,, J. Clement,, and M. Van Ranst. 2007. Evaluation of the efficacy of disinfectants against Puumala hantavirus by real-time RT-PCR. J. Virol. Methods 141: 111 115.
74. Martin, M. L.,, H. Lindsey-Regnery,, D. R. Sasso,, J. B. McCormick,, and E. Palmer. 1985. Distinction between Bunyaviridae genera by surface structure and comparison with Hantaan virus using negative stain electron microscopy. Arch. Virol. 86: 17 28.
75. Mills, J. N.,, B. R. Amman,, and G. E. Glass. 2010. Ecology of hantaviruses and their hosts in North America. Vector Borne Zoonotic Dis. 10: 563 574.
76. Mills, J. N.,, A. Corneli,, J. C. Young,, L. E. Garrison,, A. S. Khan,, and T. G. Ksiazek. 2002. Hantavirus pulmonary syndrome—United States: updated recommendations for risk reduction. MMWR Recommend. Rep. 51: 1 12.
77. Monroe, M. C.,, S. P. Morzunov,, A. M. Johnson,, M. D. Bowen,, H. Artsob,, T. Yates,, C. J. Peters,, P. E. Rollin,, T. G. Ksiazek,, and S. T. Nichol. 1999. Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg. Infect. Dis. 5: 75 86.
78. Morzunov, S. P.,, J. E. Rowe,, T. G. Ksiazek,, C. J. Peters,, S. C. St. Jeor,, and S. T. Nichol. 1998. Genetic analysis of the diversity and origin of hantaviruses in Peromyscus leucopus mice in North America. J. Virol. 72: 57 64.
79. Nichol, S. T.,, B. J. Beaty,, R. M. Elliott,, R. Goldbach,, A. Plyusnin,, C. S. Schmaljohn,, and R. B. Tesh,. 2005. Family Bunyaviridae, p. 695 716. In C. M. Fauquet,, M. A. Mayo,, J. Maniloff,, U. Desselberger,, and L. A. Ball (ed.), Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA.
80. Nichol, S. T.,, C. F. Spiropoulou,, S. Morzunov,, P. E. Rollin,, T. G. Ksiazek,, H. Feldmann,, A. Sanchez,, J. Childs,, S. Zaki,, and C. J. Peters. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262: 914 917.
81. Niklasson, B.,, M. Jonsson,, A. Lundkvist,, J. Horling,, and E. Tkachenko. 1991. Comparison of European isolates of viruses causing hemorrhagic fever with renal syndrome by a neutralization test. Am. J. Trop. Med. Hyg. 45: 660 665.
82. Niklasson, B.,, and T. Kjelsson. 1988. Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 26: 1519 1523.
83. Nolte, K. B.,, R. M. Feddersen,, K. Foucar,, S. R. Zaki,, F. T. Koster,, D. Madar,, T. L. Merlin,, P. J. McFeeley,, E. T. Umland,, and R. E. Zumwalt. 1995. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 26: 110 120.
84. Padula, P. J.,, A. Edelstein,, S. D. Miguel,, N. M. Lopez,, C. M. Rossi,, and R. D. Rabinovich. 1998. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241: 323 330.
85. Padula, P. J.,, C. M. Rossi,, M. O. Della Valle,, P. V. Martinez,, S. B. Colavecchia,, A. Edelstein,, S. D. Miguel,, R. D. Rabinovich,, and E. L. Segura. 2000. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J. Med. Microbiol. 49: 149 155.
86. Papa, A.,, H. Zelena,, D. Barnetova,, and L. Petrousova. 2010. Genetic detection of Dobrava/Belgrade virus in a Czech patient with haemorrhagic fever with renal syndrome. Clin. Microbiol. Infect. 16: 1187 1190.
87. Park, K.,, C. S. Kim,, and K. T. Moon. 2004. Protective effectiveness of hantavirus vaccine. Emerg. Infect. Dis. 10: 2218 2220.
88. Plyusnin, A. 2002. Genetics of hantaviruses: implications to taxonomy. Arch. Virol. 147: 665 682.
89. Plyusnin, A.,, Y. Cheng,, O. Vapalahti,, M. Pejcoch,, J. Unar,, Z. Jelinkova,, H. Lehvaslaiho,, A. Lundkvist,, and A. Vaheri. 1995. Genetic variation in Tula hantaviruses: sequence analysis of the S and M segments of strains from Central Europe. Virus Res. 39: 237 250.
90. Plyusnin, A.,, and S. P. Morzunov. 2001. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr. Top. Microbiol. Immunol. 256: 47 75
91. Plyusnin, A.,, A. Vaheri,, and A. Lundkvist. 2006. Saaremaa hantavirus should not be confused with its dangerous relative, Dobrava virus. J. Clin. Microbiol. 44:1608-1609. (Author’s reply, 44: 1609 1611.)
92. Plyusnin, A.,, O. Vapalahti,, and A. Vaheri. 1996. Hantaviruses: genome structure, expression and evolution. J. Gen. Virol. 77: 2677 2687.
93. Puerta, H.,, C. Cantillo,, J. Mills,, B. Hjelle,, J. Salazar-Bravo,, and S. Mattar. 2006. The new-world hantaviruses. Ecology and epidemiology of an emerging virus in Latin America. Medicina (Buenos Aires) 66: 343 356. (In Spanish.)
94. Ramsden, C.,, E. C. Holmes,, and M. A. Charleston. 2009. Hantavirus evolution in relation to its rodent and insectivore hosts: no evidence for codivergence. Mol. Biol. Evol. 26: 143 153.
95. Richmond, J. Y.,, and R. W. McKinney (ed.). 1999. Biosafety in Microbiological and Biomedical Laboratories, 4th ed. U.S. Government Printing Office, Washington, DC.
96. Riquelme, R.,, M. Riquelme,, A. Torres,, M. L. Rioseco,, J. A. Vergara,, L. Scholz,, and A. Carriel. 2003. Hantavirus pulmonary syndrome, southern Chile. Emerg. Infect. Dis. 9: 1438 1443.
97. Rusnak, J. M.,, W. R. Byrne,, K. N. Chung,, P. H. Gibbs,, T. T. Kim,, E. F. Boudreau,, T. Cosgriff,, P. Pittman,, K. Y. Kim,, M. S. Erlichman,, D. F. Rezvani,, and J. W. Huggins. 2009. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antivir. Res. 81: 68 76.
98. Saksida, A.,, D. Duh,, M. Korva,, and T. Avsic-Zupanc. 2008. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J. Infect. Dis. 197: 681 685.
99. Saluzzo, J. F.,, B. Leguenno,, and G. van der Groen. 1988. Use of heat inactivated viral haemorrhagic fever antigens in serological assays. J. Virol. Methods 22: 165 172.
100. Schmaljohn, C. 2009. Vaccines for hantaviruses. Vaccine 27( Suppl. 4): D61 D64.
101. Schmidt, J.,, B. Jandrig,, B. Klempa,, K. Yoshimatsu,, J. Arikawa,, H. Meisel,, M. Niedrig,, C. Pitra,, D. H. Kruger,, and R. Ulrich. 2005. Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity. Virus Genes 30: 37 48.
102. Schwarz, T. F.,, S. R. Zaki,, S. Morzunov,, C. J. Peters,, and S. T. Nichol. 1995. Detection and sequence confirmation of Sin Nombre virus RNA in paraffin-embedded human tissues using one-step RT-PCR. J. Virol. Methods 51: 349 356.
103. Severson, W. E.,, C. S. Schmaljohn,, A. Javadian,, and C. B. Jonsson. 2003. Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol. 77: 481 488.
104. Sibold, C.,, H. Meisel,, D. H. Kruger,, M. Labuda,, J. Lysy,, O. Kozuch,, M. Pejcoch,, A. Vaheri,, and A. Plyusnin. 1999. Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J. Virol. 73: 667 675.
105. Sironen, T.,, A. Vaheri,, and A. Plyusnin. 2001. Molecular evolution of Puumala hantavirus. J. Virol. 75: 11803 11810.
106. Sjolander, K. B.,, and A. Lundkvist. 1999. Dobrava virus infection: serological diagnosis and cross-reactions to other hantaviruses. J. Virol. Methods 80: 137 143.
107. Sohn, Y. M.,, H. O. Rho,, M. S. Park,, J. S. Kim,, and P. L. Summers. 2001. Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea. Yonsei Med. J. 42: 278 284.
108. Song, G.,, Y. C. Huang,, C. S. Hang,, F. Y. Hao,, D. X. Li,, X. L. Zheng,, W. M. Liu,, S. L. Li,, Z. W. Huo,, L. J. Huei,, and Q. F. Zhang. 1992. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS). Vaccine 10: 214 216.
109. Song, J. W.,, L. J. Baek,, C. S. Schmaljohn,, and R. Yanagihara. 2007. Thottapalayam virus, a prototype shrewborne hantavirus. Emerg. Infect. Dis. 13: 980 985.
110. Tsai, T. F. 1987. Hemorrhagic fever with renal syndrome: mode of transmission to humans. Lab. Anim. Sci. 37: 428 430.
111. Vaheri, A.,, O. Vapalahti,, and A. Plyusnin. 2008. How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev. Med. Virol. 18: 277 288.
112. Valdivieso, F.,, P. Vial,, M. Ferres,, C. Ye,, D. Goade,, A. Cuiza,, and B. Hjelle. 2006. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerg. Infect. Dis. 12: 166 168.
113. Van Loock, F.,, I. Thomas,, J. Clement,, S. Ghoos,, and P. Colson. 1999. A case-control study after a hantavirus infection outbreak in the south of Belgium: who is at risk? Clin. Infect. Dis. 28: 834 839.
114. Vapalahti, O.,, A. Lundkvist,, V. Fedorov,, C. J. Conroy,, S. Hirvonen,, A. Plyusnina,, K. Nemirov,, K. Fredga,, J. A. Cook,, J. Niemimaa,, A. Kaikusalo,, H. Henttonen,, A. Vaheri,, and A. Plyusnin. 1999. Isolation and characterization of a hantavirus from Lemmus sibiricus: evidence for host switch during hantavirus evolution. J. Virol. 73: 5586 5592.
115. Vapalahti, O.,, J. Mustonen,, A. Lundkvist,, H. Henttonen,, A. Plyusnin,, and A. Vaheri. 2003. Hantavirus infections in Europe. Lancet Infect. Dis. 3: 653 661.
116. Weidmann, M.,, P. Schmidt,, M. Vackova,, K. Krivanec,, P. Munclinger,, and F. T. Hufert. 2005. Identification of genetic evidence for Dobrava virus spillover in rodents by nested reverse transcription (RT)-PCR and TaqMan RTPCR. J. Clin. Microbiol. 43: 808 812.
117. Wells, R. M.,, S. Sosa Estani,, Z. E. Yadon,, D. Enria,, P. Padula,, N. Pini,, J. N. Mills,, C. J. Peters,, E. L. Segura, and the Hantavirus Pulmonary Syndrome Study Group for Patagonia. 1997. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerg. Infect. Dis. 3: 171 174.
118. Wong, T. W.,, Y. C. Chan,, E. H. Yap,, Y. G. Joo,, H. W. Lee,, P. W. Lee,, R. Yanagihara,, C. J. Gibbs, Jr.,, and D. C. Gajdusek. 1988. Serological evidence of hantavirus infection in laboratory rats and personnel. Int. J. Epidemiol. 17: 887 890.
119. Woods, C.,, R. Palekar,, P. Kim,, D. Blythe,, O. de Senarclens,, K. Feldman,, E. C. Farnon,, P. E. Rollin,, C. G. Albarino,, S. T. Nichol,, and M. Smith. 2009. Domestically acquired Seoul virus causing hemorrhagic fever with renal syndrome—Maryland, 2008. Clin. Infect. Dis. 49: e109 e112.
120. Xiao, R.,, S. Yang,, F. Koster,, C. Ye,, C. Stidley,, and B. Hjelle. 2006. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J. Infect. Dis. 194: 1403 1409.
121. Xiao, S. Y.,, Y. K. Chu,, F. K. Knauert,, R. Lofts,, J. M. Dalrymple,, and J. W. LeDuc. 1992. Comparison of hantavirus isolates using a genus-reactive primer pair polymerase chain reaction. J. Gen. Virol. 73: 567 573.
122. Xiao, S. Y.,, J. W. Leduc,, Y. K. Chu,, and C. S. Schmaljohn. 1994. Phylogenetic analyses of virus isolates in the genus Hantavirus, family Bunyaviridae. Virology 198: 205 217.
123. Yamanishi, K.,, O. Tanishita,, M. Tamura,, H. Asada,, K. Kondo,, M. Takagi,, I. Yoshida,, T. Konobe,, and K. Fukai. 1988. Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome. Vaccine 6: 278 282.
124. Yashina, L. N.,, N. A. Patrushev,, L. I. Ivanov,, R. A. Slonova,, V. P. Mishin,, G. G. Kompanez,, N. I. Zdanovskaya,, I. I. Kuzina,, P. F. Safronov,, V. E. Chizhikov,, C. Schmaljohn,, and S. V. Netesov. 2000. Genetic diversity of hantaviruses associated with hemorrhagic fever with renal syndrome in the far east of Russia. Virus Res. 70: 31 44.
125. Ye, C.,, J. Prescott,, R. Nofchissey,, D. Goade,, and B. Hjelle. 2004. Neutralizing antibodies and Sin Nombre virus RNA after recovery from hantavirus cardiopulmonary syndrome. Emerg. Infect. Dis. 10: 478 482.
126. Zaki, S. R.,, P. W. Greer,, L. M. Coffield,, C. S. Goldsmith,, K. B. Nolte,, K. Foucar,, R. M. Feddersen,, R. E. Zumwalt,, G. L. Miller,, A. S. Khan,, P. E. Rollin,, T. G. Ksiazek,, S. T. Nichol,, B. W. J. Mahy,, and C. J. Peters. 1995. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146: 552 579.
127. Zaki, S. R.,, A. S. Khan,, R. A. Goodman,, L. R. Armstrong,, P. W. Greer,, L. M. Coffield,, T. G. Ksiazek,, P. E. Rollin,, C. J. Peters,, and R. F. Khabbaz. 1996. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Arch. Pathol. Lab. Med. 120: 134 139.

Tables

Generic image for table
TABLE 1

Hantaviral species associated with human disease

Adapted from references , and . Amur virus has been associated with HFRS in eastern Russia; is the natural host. Additional hantaviruses associated with HPS include Monongahela virus in the United States; Central Plata virus in Uruguay; Choclo virus in Panama; Bermejo, Lechiguanas, and Oran viruses in Argentina; and Anajatuba, Araraquara, Castelo dos Sonhos, and Juquitiba viruses in Brazil. Monongahela virus is a strain of Sin Nombre virus, and Bermejo, Lechiguanas, and Oran viruses are considered strains of Andes virus. Sigmodontine rodents are the natural hosts of Anajatuba, Araraquara, Bermejo, Central Plata, Choclo, Juquitiba, Lechiguanas, and Oran viruses. The natural host of Castelo dos Sonhos virus is not known.

Murinae, Old World rats and mice; Arvicolinae, voles and lemmings; Sigmodontinae and Neotominae, New World rats and mice.

Citation: Fulhorst C, Bowen M. 2011. Hantaviruses, p 1504-1513. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch94

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error